Resources

Client Alerts, News Articles, Blog Posts, & Multimedia

Everything you need to know about BMD and the industry.

Advanced Practice Providers and Telemedicine Start-Up Surge

Client Alert

Overview:

Throughout the COVID-19 pandemic, we heard a lot about “surges” that happened all over the country regarding the virus.  One of the other interesting “surges” we have followed is the “surge” in new healthcare business start-ups, particularly businesses owned by advanced practice providers, such as nurse practitioners, physician assistants, certified nurse midwives, clinical nurse specialists, and certified registered nurse anesthetists (“Advanced Practice Providers” or “APPs”).  One of the hottest areas in the healthcare start-up surge has been the creation of practices that are telemedicine focused.  

While telemedicine is not a new concept, the number of practices and providers actually utilizing telemedicine has increased dramatically since the start of the pandemic. With this soar, providers, particularly APPs, have increasingly asked for assistance with appropriately structuring these new businesses and tackling questions regarding their telemedicine scope of practice and their ability to prescribe medications to patients who have not received an in-person examination. This article will address common questions that we have been asked by APPs trying to implement telemedicine in their own practices.

Scope of Practice:

The first things to remember with regard to telemedicine is that a provider must generally follow the laws and regulations of the state where the patient is located at the time of the visit.  With regards to scope of practice for APPs using telemedicine, it is important to note that this is rapidly changing, particularly because the drive for APP autonomy and full practice authority is in full force across the country, and each state’s scope of practice rules and regulations are different. 

Additionally, each state has wide variation in their telemedicine laws governing scope of practice while utilizing telemedicine, and those parameters have been changing quickly.  For example, in Pennsylvania, there were no telemedicine statutes in place prior to the pandemic, which meant rules neither prohibited nor authorized the use of telemedicine. However, Senate Bill 705 was introduced in 2021, which addressed the regulation of telemedicine by professional licensing boards and insurance coverage for services provided via telemedicine. 

Similarly, in Ohio, as a result of the pandemic, House Bill 122 was passed and will take effect March 23, 2022. As a result, Ohio Revised Code § 4743.09 lists advanced practice registered nurses and physician assistants among those health care professionals permitted to provide services via telemedicine, using either synchronous or asynchronous technology. Essentially, through this rule, the Ohio Board of Nursing (for APRNs) and Board of Medicine (for PAs) are granted permission to implement telemedicine rules in order to carry out the Bill. 

Prescribing to patients who an APP has not seen in person is another issue that has presented itself during the pandemic, with many states’ scope of practice laws not addressing the issue. However, states such as Virginia, for example, have implemented remote prescribing rules, focusing primarily on limitations associated with prescribing controlled substances.[1] With telemedicine being widely used since the start of the pandemic, it is likely that states and licensing boards will begin implementing more concrete rules related to remote prescribing, if they have not done so already.

Billing:

Another common category of telemedicine questions relates to what services providers can provide to patients utilizing telemedicine, and how these services are to be billed. For Medicare patients, the Centers for Medicare and Medicaid Services (“CMS”) has provided a list of services that may be reimbursed if provided via telemedicine in their “List of Telehealth Services for Calendar Year 2022.” 

While state Medicaid programs usually try to mirror Medicare, not all requirements will be the same. As such, it is important for nurse practitioners to look at their state’s Medicaid laws addressing telehealth in order to determine what services are covered and review any additional requirements there may be.     

Commercial insurers are also likely to list the telemedicine services they cover for reimbursement. Additionally, many states have implemented rules protecting coverage of telemedicine services. For example, in Missouri, health carriers and health benefit plans cannot deny coverage for a service solely because it was rendered via telemedicine if the service would have been reimbursed if the patient was seen in person.[2] Ohio’s H.B. 122 includes similar protections that require insurers to reimburse for telemedicine services. 

If you have any questions about healthcare business start-ups, telemedicine scope of practice, prescribing guidelines, reimbursement rules, or any other healthcare legal issues that arise, please contact Jeana Singleton by email at: jmsingleton@bmdllc.com, or by phone at: (330) 253-2001.

[1] Virginia Code § 38.2-3418.16.

[2] Missouri Statute § 376.1900.


RNs and APRNs Take Note: Ohio Board of Nursing Mandates a New CE Reporting Period

Ohio’s Board of Nursing has updated the continuing education reporting period for RNs and APRNs. Beginning March 26, 2026, CE credits must be completed between July 1 and June 30 of odd-numbered years, replacing the previous November to October timeframe.

Ohio Med Spas: Peptide Do's and Do Not's

Recent guidance from the Ohio Board of Pharmacy outlines key compliance requirements for med spas using peptides. While some peptide drugs are FDA approved, others are not or cannot be compounded. Med spa operators should ensure they source medications from licensed suppliers, avoid non-approved or “research use only” products, and follow all compounding and storage regulations to maintain compliance and avoid enforcement actions.

Substance Use Disorder Providers: 42 CFR Part 2 Now Enforceable

Updates to 42 CFR Part 2 are now enforceable, bringing significant changes to how substance use disorder (SUD) records are handled. The Final Rule aligns Part 2 more closely with HIPAA, introduces updated penalties, allows a single patient consent for treatment, payment, and operations, and adds new requirements for Notices of Privacy Practices. It also creates a formal definition of SUD counseling notes and imposes strict consent requirements for their use and disclosure. Providers should review and update policies to ensure compliance.

AAA Introduces AI-Assisted Arbitrator for Certain Disputes

The American Arbitration Association has introduced an AI-assisted arbitration platform designed to streamline certain document-based disputes. While a human arbitrator still makes the final decision, the technology can improve efficiency, reduce costs, and accelerate case resolution. Companies should weigh these benefits against considerations such as transparency, risk, and contractual requirements before adopting AI-assisted arbitration.

Quiet Hours Texts and TCPA Claims: Consent Remains King as Courts Divide on Text Messages

Businesses face increasing TCPA lawsuits over off-hours marketing texts, but recent court decisions highlight strong defenses. Clear consumer consent and updated terms and conditions can defeat many claims, while a growing number of courts are finding that text messages are not “telephone calls” under the statute. Proactive compliance measures, including clickwrap agreements and forum-selection clauses, are critical to reducing risk.